NEW DELHI: Hospital chain Fortis Healthcare said on Thursday it will buy an 86-percent stake in diagnostic services firm Super Religare Laboratories Ltd (SRL) to expand its business verticals.
SRL, which filed with regulators for an initial public offering (IPO) in February, is awaiting comments from the capital markets regulator, Securities and Exchange Board of India, Fortis said in a statement.
Both Fortis and Religare are controlled by billionaire brothers Malvinder and Shivinder Singh, but are different companies in the healthcare business.
Source: PTI
